Royalty Pharma plc Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 1517.86M2461.42M1701.95M1241.20M230.06M1700.09M1330.81M
Gains from Investment Securities 39.40M27.04M42.33M34.85M39.14M18.82M18.00M
Cash from Operations 1618.32M1667.24M2034.63M2017.54M2143.98M2987.80M2768.99M
Investing Activities
Capital Expenditures 269.59M1721.29M2182.25M2191.50M1741.64M2115.52M2505.70M
Divestments 15.08M0.52M43.88M23.64M
Change in Acquisitions & Divestments 750.00M725.07M815.44M1597.85M792.34M24.39M19.79M
Cash from Investing Activities 303.42M-2153.62M-2759.32M-1870.28M-1029.42M-2072.79M-2678.11M
Financing Activities
Other financing activities 2.05M46.72M13.05M1.35M1.60M12.62M
Cash from Financing Activities -1379.10M-1191.63M1487.17M385.11M-944.86M-2148.75M361.14M
Dividend Payments
Dividends Paid - Common 268.69M154.08M113.48M133.43M144.12M119.53M125.16M
Additional items
Change in Cash 542.64M-1678.01M762.48M532.37M169.70M-1233.74M452.02M
Free Cash Flow 1348.72M-54.05M-147.62M-173.97M402.34M872.28M263.29M
Net Cash Flow 542.64M-1678.01M762.48M532.37M169.70M-1233.74M452.02M